CAR T-Cell Therapy for Glioblastoma
New England Journal of Medicine · 2024
DOI: 10.1056/nejme2401307 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Misty R Jenkins und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Immunology Division, Walter and Eliza Hall Institute, and the Department of Medical Biology, University of Melbourne, Parkville, VIC (M.R.J.…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma is the most formidable of primary brain tumors, owing to its aggressive nature and the limited efficacy of the best available treatment, which comprises maximal safe surgical resection, radiotherapy, and alkylating chemotherapy. Most patients die within a year after diagnosis, which underscores the urgent need for innovative therapeutic strategies. Of interest, then, is an interim analysis in this issue of the Journal : Choi et al. 1 report the outcomes of treating three patients with a secreting chimeric antigen receptor (CAR) T cell (see Key Concepts). CAR T-cell technology has reshaped our therapeutic approach to combating hematologic cancers. It harnesses the . . .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Immunology Division, Walter and Eliza Hall Institute, and the Department of Medical Biology, University of Melbourne, Parkville, VIC (M.R.J.), and the Department of Surgery, University of Melbourne, Melbourne,…
Zitieren
APA
Jenkins, M. R., & Drummond, K. J. (2024). CAR T-Cell Therapy for Glioblastoma. New England Journal of Medicine. https://doi.org/10.1056/nejme2401307
Vancouver
Jenkins MR, Drummond KJ. CAR T-Cell Therapy for Glioblastoma. New England Journal of Medicine. 2024. doi:10.1056/nejme2401307
BibTeX
@article{Jenkins2024,
author = {Jenkins, Misty R and Drummond, Katharine J},
title = {CAR T-Cell Therapy for Glioblastoma},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejme2401307}
}
EUVIMED